Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Bezafibrate therapy in primary biliary cholangitis refractory to ursodeoxycholic acid: a longitudinal study of paired liver biopsies at 5 years of follow up
Sorda, Juan Antonio, González Ballerga, Esteban, Barreyro, Fernando Javier, Avagnina, Alejandra, Carballo, Pilar, Paes de Lima, Andrea, Daruich, Jorge
Published in Alimentary pharmacology & therapeutics (01.11.2021)
Published in Alimentary pharmacology & therapeutics (01.11.2021)
Get full text
Journal Article
Peroxisome Proliferator-Activated Receptors α and γ are Linked with Alcohol Consumption in Mice and Withdrawal and Dependence in Humans
Blednov, Yuri A., Benavidez, Jillian M., Black, Mendy, Ferguson, Laura B., Schoenhard, Grant L., Goate, Alison M., Edenberg, Howard J., Wetherill, Leah, Hesselbrock, Victor, Foroud, Tatiana, Adron Harris, R.
Published in Alcoholism, clinical and experimental research (01.01.2015)
Published in Alcoholism, clinical and experimental research (01.01.2015)
Get full text
Journal Article
Effects of Peroxisome Proliferator-Activated Receptor Ligands, Bezafibrate and Fenofibrate, on Adiponectin Level
Hiuge, Aki, Tenenbaum, Alexander, Maeda, Norikazu, Benderly, Michal, Kumada, Masahiro, Fisman, Enrique Z., Tanne, David, Matas, Zipora, Hibuse, Toshiyuki, Fujita, Koichi, Nishizawa, Hitoshi, Adler, Yehuda, Motro, Michael, Kihara, Shinji, Shimomura, Iichiro, Behar, Solomon, Funahashi, Tohru
Published in Arteriosclerosis, thrombosis, and vascular biology (01.03.2007)
Published in Arteriosclerosis, thrombosis, and vascular biology (01.03.2007)
Get full text
Journal Article
Bezafibrate, a peroxisome proliferator–activated receptor α agonist, decreases circulating CD14+CD16+ monocytes in patients with type 2 diabetes
Terasawa, Tomoko, Aso, Yoshimasa, Omori, Kyoko, Fukushima, Maiko, Momobayashi, Atsushi, Inukai, Toshihiko
Published in Translational research : the journal of laboratory and clinical medicine (01.02.2015)
Published in Translational research : the journal of laboratory and clinical medicine (01.02.2015)
Get full text
Journal Article
Bezafibrate Mildly Stimulates Ketogenesis and Fatty Acid Metabolism in Hypertriglyceridemic Subjects
Tremblay-Mercier, Jennifer, Tessier, Daniel, Plourde, Mélanie, Fortier, Mélanie, Lorrain, Dominique, Cunnane, Stephen C.
Published in The Journal of pharmacology and experimental therapeutics (01.07.2010)
Published in The Journal of pharmacology and experimental therapeutics (01.07.2010)
Get full text
Journal Article
Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease
Koga, Hidenobu, Sugiyama, Seigo, Kugiyama, Kiyotaka, Fukushima, Hironobu, Watanabe, Keisuke, Sakamoto, Tomohiro, Yoshimura, Michihiro, Jinnouchi, Hideaki, Ogawa, Hisao
Published in European heart journal (01.04.2006)
Published in European heart journal (01.04.2006)
Get full text
Journal Article
VLDL triglycerides inhibit HDL-associated paraoxonase 1 (PON1) activity: in vitro and in vivo studies
Rosenblat, Mira, Ward, Sarah, Volkova, Nina, Hayek, Tony, Aviram, Michael
Published in BioFactors (Oxford) (01.07.2012)
Published in BioFactors (Oxford) (01.07.2012)
Get full text
Journal Article
Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study
Elkeles, Robert S, Diamond, Judith R, Poulter, Clare, Dhanjil, Surinder, Nicolaides, Andrew N, Mahmood, Shahid, Richmond, William, Mather, Hugh, Sharp, Patrick, Feher, Michael D
Published in Diabetes care (01.04.1998)
Published in Diabetes care (01.04.1998)
Get full text
Journal Article
Evidence for a role of tumor necrosis factor α in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease
Jovinge, Stefan, Hamsten, Anders, Tornvall, Per, Proudler, Anthony, Båvenholm, Peter, Ericsson, Carl-Göran, Godsland, Ian, de Faire, Ulf, Nilsson, Jan
Published in Metabolism, clinical and experimental (1998)
Published in Metabolism, clinical and experimental (1998)
Get full text
Journal Article
Combination peroxisome proliferator-activated receptor γ and α agonist treatment in Type 2 diabetes prevents the beneficial pioglitazone effect on liver fat content
Balasubramanian, R., Gerrard, J., Dalla Man, C., Firbank, M. J., Lane, A., English, P. T., Cobelli, C., Taylor, R.
Published in Diabetic medicine (01.02.2010)
Published in Diabetic medicine (01.02.2010)
Get full text
Journal Article
Bezafibrate induces FALDH in human fibroblasts; implications for Sjögren-Larsson syndrome
Gloerich, J., IJlst, L., Wanders, R.J.A., Ferdinandusse, S.
Published in Molecular genetics and metabolism (01.09.2006)
Published in Molecular genetics and metabolism (01.09.2006)
Get full text
Journal Article
C-reactive protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease
Haim, Moti, Benderly, Michal, Tanne, David, Matas, Zipora, Boyko, Valentina, Fisman, Enrique Z., Tenenbaum, Alexander, Zimmlichman, Reuven, Battler, Alexander, Goldbourt, Uri, Behar, Solomon
Published in The American heart journal (01.12.2007)
Published in The American heart journal (01.12.2007)
Get full text
Journal Article
Effects of bezafibrate on lipoprotein subclasses and inflammatory markers in patients with hypertriglyceridemia—a nuclear magnetic resonance study
Ikewaki, Katsunori, Noma, Kenji, Tohyama, Jun-ichiro, Kido, Toshimi, Mochizuki, Seibu
Published in International journal of cardiology (08.06.2005)
Published in International journal of cardiology (08.06.2005)
Get full text
Journal Article
Chitotriosidase genotype and serum activity in subjects with combined hyperlipidemia: Effect of the lipid-lowering agents, atorvastatin and bezafibrate
Canudas, J., Cenarro, A., Civeira, F., Garcı́-Otı́n, A.L., Arı́stegui, R., Dı́az, C., Masramon, X., Sol, J.M., Hernández, G., Pocovı́, M.
Published in Metabolism, clinical and experimental (01.04.2001)
Published in Metabolism, clinical and experimental (01.04.2001)
Get full text
Journal Article
Genetic variation in the hepatic lipase gene is associated with combined hyperlipidemia, plasma lipid concentrations, and lipid-lowering drug response
Cenarro, Ana, Artieda, Marta, Gonzalvo, Carmen, Meriño-Ibarra, Erardo, Arístegui, Rosa, Gañán, Alberto, Díaz, Cristina, María Sol, Josep, Pocoví, Miguel, Civeira, Fernando
Published in The American heart journal (01.12.2005)
Published in The American heart journal (01.12.2005)
Get full text
Journal Article
Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?
Tenenbaum, Alexander, Boyko, Valentina, Fisman, Enrique Z, Goldenberg, Ilan, Adler, Yehuda, Feinberg, Micha S, Motro, Michael, Tanne, David, Shemesh, Joseph, Schwammenthal, Ehud, Behar, Solomon
Published in Cardiovascular diabetology (19.06.2008)
Published in Cardiovascular diabetology (19.06.2008)
Get full text
Journal Article